Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic.
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients.
Multiple sclerosis and pain.
Superficial spreading malignant melanoma in a patient on fingolimod therapy for multiple sclerosis.
Natalizumab-induced autoimmune hepatitis in a patient with multiple sclerosis.
The nocebo effect: A clinicians guide.
T-cell response against varicella-zoster virus in fingolimod-treated MS patients.
Central Nervous System and its Disease Models on a Chip.
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Warner Chilcott sells Vectrin product line to Medicis
IgM antibody identifies good candidates for natalizumab
[Unified assessment of adverse events of multiple sclerosis disease modifying drugs.]
Multiple sclerosis and bipolar disorders: The burden of comorbidity and its consequences on quality of life.
Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States.
White matter atrophy and cognitive dysfunctions in neuromyelitis optica.
Granzyme B-Induced Neurotoxicity Is Mediated via Activation of PAR-1 Receptor and Kv1.3 Channel.
A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue.
Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses.
Leukocyte infiltration across the blood-spinal cord barrier is modulated by sleep fragmentation in mice with experimental autoimmune encephalomyelitis.
The validity and reliability of the neurogenic bladder symptom score (NBSS).
Dalfampridine improves walking speed, walking endurance, and community participation in veterans with multiple sclerosis: a longitudinal cohort study.
Suppression of Brain Mast Cells Degranulation Inhibits Microglial Activation and Central Nervous System Inflammation.
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
Topographical and Biological Evidence Revealed FTY720-Mediated Anergy-Polarization of Mouse Bone Marrow-Derived Dendritic Cells In Vitro.
Riluzole inhibits spontaneous Ca2+ signaling in neuroendocrine cells by activation of K+ channels and inhibition of Na+ channels.
Pages
« first
‹ previous
…
195
196
197
198
199
200
201
202
203
…
next ›
last »